Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
J Pediatr ; 273: 114144, 2024 Oct.
Article in English | MEDLINE | ID: mdl-38876155

ABSTRACT

We investigated the uptake of nirsevimab for infants and the bivalent respiratory syncytial virus prefusion F (RSVPreF) vaccine for pregnant persons as measures for RSV prevention during an infant's birth hospitalization in a military treatment facility. We found >85% uptake between October 2023 to February 2024. These data may aid health systems plan for future RSV seasons.


Subject(s)
Respiratory Syncytial Virus Infections , Humans , Infant, Newborn , Respiratory Syncytial Virus Infections/prevention & control , Female , Pregnancy , Respiratory Syncytial Virus Vaccines , Antibodies, Monoclonal, Humanized/therapeutic use , Antiviral Agents/therapeutic use , Military Personnel , Male , Hospitalization/statistics & numerical data
SELECTION OF CITATIONS
SEARCH DETAIL